Trial intelligence / Profile preview

Atosiban in IVF Treatment

NCT01501214Phase 4Completed

Sponsor
The University of Hong Kong
Start
Dec 2011
Primary completion
Dec 2013
Modality
Peptides, Small Molecules
Countries
2
01

Overview

Phase 4, randomised, double-blind trial in infertility comparing Atosiban with Placebo (2 arms). Primary endpoint: Live birth rate at 9 months. Started Dec 2011; status: completed.

02

Drugs

atosiban
03

Conditions

infertility

Beyond the preview

Go deeper on NCT01501214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01501214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call